Sandro Wealth Management’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Other funds holding ROIV
Sandro Wealth Management's ROIV Position: Q3 2026 in Review
Sandro Wealth Management held its Roivant Sciences (ROIV) position steady in Q3 2026 at 90,130 shares worth $3.3M. The position accounts for 2.13% of the portfolio, ranked #10.
Sandro Wealth Management first reported a position in ROIV in Q4 2025 and has held it in 4 quarters since. 522 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.
- Sandro Wealth Management held 90,130 shares of Roivant Sciences worth $3.3M as of Q3 2026.
- Sandro Wealth Management left its Roivant Sciences share count unchanged in Q3 2026.
- Roivant Sciences made up 2.13% of Sandro Wealth Management's portfolio in Q3 2026, its #10 holding.
- Sandro Wealth Management first reported a position in Roivant Sciences in Q4 2025 and has held it in 4 quarters since.
- 522 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.
Based on Sandro Wealth Management's 13F filing for Q3 2026, filed 12 Nov 2026.